Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Introduction<p>Although the transcatheter arterial chemoembolization (TACE) combined with sintilimab and bevacizumab improves outcomes in unresectable HCC (uHCC), predictive tools are lacking. This study developed and validated a prognostic model for triple therapy efficacy.</p>Methods&l...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: Liying Ren (11143129) (author)
Övriga upphovsmän: Dongbo Chen (10430738) (author), Xue Zhang (166886) (author), Shaoping She (22678979) (author), Ran Fei (93650) (author), Xu Cong (159269) (author), Shaowei Mu (22678982) (author), Yuchen Zhou (1601536) (author), Jie Gao (10266) (author), Weijia Liao (492662) (author), Hongsong Chen (159274) (author)
Publicerad: 2025
Ämnen:
Genetic Immunology
hepatocellular carcinoma
immunotherapy
transcatheter arterial chemoembolization
prognostic model
FAAP score
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!
Lägg till första kommentaren!
Du måste logga in först

Liknande verk